Motif Bio plc (LSE: MTFB, NASDAQ: MTFB) is developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria.
Total raised: $3.572682M
Investors 1
| Date | Name | Website |
| - | Amphion In... | amphionplc... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 26.03.2019 | - | $3.572682M | - | biospace.c... |
Mentions in press and media 2
| Date | Title | Description | Category | Author | Source |
| 18.04.2017 | Celgene, ... | A host of biotech startups in... | - | Shehla Sha... | endpts.com... |
| 31.10.2016 | Motif Bio ... | Motif Bio (LON:MTFB) has warne... | Biotech | - | fiercebiot... |